| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/22/2010 | WO2010044405A1 Fused-ring derivative and medical application of same |
| 04/22/2010 | WO2010044404A1 Fused heterocyclic derivative and use thereof for medical purposes |
| 04/22/2010 | WO2010044403A1 5-membered heteroaryl derivative and use thereof for medical purposes |
| 04/22/2010 | WO2010043153A1 Fusion protein inhibiting osteoclast formation, preparation method and drug compositions thereof |
| 04/22/2010 | WO2010043073A1 Collagen polypeptide, preparation method and uses thereof |
| 04/22/2010 | WO2010022083A9 Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof |
| 04/22/2010 | WO2010011879A3 Methods and compositions for treating and preventing autoimmune diseases |
| 04/22/2010 | WO2010009111A3 A drug depot implantable within a synovial joint |
| 04/22/2010 | WO2009151770A3 Colchicine solid-state forms; methods of making; and methods of use thereof |
| 04/22/2010 | WO2009143363A3 Functional metabolomics coupled microfluidic chemotaxis device and identification of novel cell mediators |
| 04/22/2010 | US20100099729 Nitric oxide donor compounds |
| 04/22/2010 | US20100099723 Bioavailable compositions of metaxalone and processes for producing the same |
| 04/22/2010 | US20100099691 Pyrimidinyl pyridone inhibitors of jnk |
| 04/22/2010 | US20100099673 Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| 04/22/2010 | US20100099670 Benzoquinazoline derivatives |
| 04/22/2010 | US20100099659 Inhibitors of Bruton's Tyrosine Kinase |
| 04/22/2010 | US20100099637 Use of cycloartane compounds for treating arthritis |
| 04/22/2010 | US20100098762 Thermosensitive Pluronic Derivative Hydrogels With High Biodegradability And Biocompatibility For Tissue Regeneration And Preparation Method Thereof |
| 04/22/2010 | US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer |
| 04/22/2010 | US20100098687 Compositions and methods for treating thymic stromal lymphopoietin (tslp)-mediated conditions |
| 04/22/2010 | US20100098684 Biomarkers and methods for detecting and treating spinal and joint pain |
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | US20100098673 Bone graft composites and methods of treating bone defects |
| 04/22/2010 | US20100098670 Autologous dental pulp stem cell-based bone graft substitute |
| 04/22/2010 | US20100098659 Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions |
| 04/22/2010 | US20100098629 Novel Amides Acting on the Adenosine Receptors |
| 04/22/2010 | CA2739488A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2739060A1 Fused-ring derivative and medical application of same |
| 04/22/2010 | CA2739058A1 Fused heterocyclic derivative and use thereof for medical purposes |
| 04/22/2010 | CA2738929A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2737775A1 Trpv1 antagonists |
| 04/22/2010 | CA2737768A1 Trpv1 antagonists |
| 04/22/2010 | CA2735834A1 A medicinal product and treatment |
| 04/21/2010 | EP2177530A1 Octapeptide having antiangiogenic activity |
| 04/21/2010 | EP2177517A1 Amino substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimide for reducing TNF alpha levels |
| 04/21/2010 | EP2177513A1 Phenylacetic acid compound |
| 04/21/2010 | EP2177219A1 Preventive agent or therapeutic agent for disease caused by abnormal bone metabolism |
| 04/21/2010 | EP2176294A1 Mdl-1 uses |
| 04/21/2010 | EP2176247A2 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 04/21/2010 | EP2176220A2 Pyrrolidin-2-one derivatives as androgen receptor modulator |
| 04/21/2010 | EP2175869A1 Repair of lesions in cartilage and bone using a chondro-regulative matrix |
| 04/21/2010 | EP1888584B1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
| 04/21/2010 | EP1761494B1 Chemical compounds i |
| 04/21/2010 | EP1610780B1 Cyclic protein tyrosine kinase inhibitors |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | EP1258252B1 Integrin expression inhibitors |
| 04/21/2010 | EP0910369B1 Benzothiophenes, formulations containing same, and methods |
| 04/21/2010 | EP0870033B1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 04/21/2010 | CN1943635B Chinese traditional medicinal preparation for treating bone injuries and osteonosus |
| 04/21/2010 | CN1891267B Chinese medicine for treating atrophic arthritis |
| 04/21/2010 | CN1864704B Herbal composition for treatment of arthritic disorders, skin inflammatory disorders and pain |
| 04/21/2010 | CN1839974B Medicine composition for treating rheumatoid disease and method for preparing the same |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN1689628B Medical purpose of creat extract |
| 04/21/2010 | CN101696247A Method for preparing moisturizing agent N-maleylation-O-carboxymethyl chitosan |
| 04/21/2010 | CN101696243A Human genetic engineering antibody TRD 109 as well as preparation method and application thereof |
| 04/21/2010 | CN101696234A Polypeptide for resisting rheumatoid arthritis and application thereof in pharmacy |
| 04/21/2010 | CN101696183A (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof |
| 04/21/2010 | CN101695559A Ointment for treating osteoarthropathy and preparation method thereof |
| 04/21/2010 | CN101695558A Traditional Chinese medicinal composition for treating traumatic injury and rheumatism paralysis and preparation method thereof |
| 04/21/2010 | CN101209276B China elder medicinal liqueur for expelling wind dissipating blood stasis and activating collateral flow |
| 04/20/2010 | US7700763 3-triazolyl-galactoside inhibitors of galectins |
| 04/20/2010 | US7700657 Vitamin D analogs |
| 04/20/2010 | US7700562 Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700361 Secretory or membrane protein expressed in skeletal muscles |
| 04/20/2010 | CA2435392C Desiccated avian sternal cartilage powder |
| 04/20/2010 | CA2417207C Dental products comprising bone growth enhancing peptide |
| 04/20/2010 | CA2388240C Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/20/2010 | CA2134756C Selectin variants |
| 04/15/2010 | WO2010042642A1 Calcium receptor modulating agents |
| 04/15/2010 | WO2010041963A1 Treating or preventing gout |
| 04/15/2010 | WO2010041726A1 Substituted tricyclic heteroaryl compound |
| 04/15/2010 | WO2010041716A1 Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue |
| 04/15/2010 | WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 04/15/2010 | WO2010022249A3 Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
| 04/15/2010 | WO2009143018A3 Pyrrolo [2, 3-d] pyrimidines as fm and kit kinase modulators |
| 04/15/2010 | WO2009110003A8 Novel flavonol compounds, a bioactive extract/fraction from ulmus wallichiana and its compounds for prevention for treatment of osteo-health related disorders |
| 04/15/2010 | US20100093853 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| 04/15/2010 | US20100093843 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of cartilage degradation or cartilage damage in joints |
| 04/15/2010 | US20100093838 Regulation of angiogenesis with zinc finger proteins |
| 04/15/2010 | US20100093833 Methods for Inducing Differentiation of Undifferentiated Mammalian Cells Into Osteoblasts |
| 04/15/2010 | US20100093825 Bicycloester derivative |
| 04/15/2010 | US20100093820 Crystalline pyrazoles |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093799 For reducing levels of tumor necrosis factor alpha in mammals; 3-(3-Nitrophthalimido)-3-methylpiperidine-2,6-dione; 1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)-5-nitroisoindoline |
| 04/15/2010 | US20100093798 Cyclic modulators of chemokine receptor activity |
| 04/15/2010 | US20100093790 Isoquinoline compounds |
| 04/15/2010 | US20100093769 Compounds |
| 04/15/2010 | US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 04/15/2010 | US20100093678 Compositions and methods of the treatment of obesity and osteoporosis |
| 04/15/2010 | US20100093628 Methods of treatment using wisp polypeptides |
| 04/15/2010 | US20100093622 method of producing native components, such as growth factors or extracellular matrix proteins, through cell culturing of tissue samples for tissue repair |
| 04/15/2010 | US20100093614 Novel Composition for Tumor Growth Control |
| 04/15/2010 | US20100093612 Integrin targeted cyclopeptide ligands, their preparation and use |
| 04/15/2010 | US20100093003 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 04/15/2010 | US20100092559 Boldine compounds for promoting bone growth |
| 04/15/2010 | US20100092558 Method for Producing a Product Having a Polymer Matrix, Implants Made Thereof and Use Thereof |
| 04/15/2010 | US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom |